IPO of AbCellera Biologics.

AbCellera Biologics, Inc. has placed 24 150 000 shares of common stock in an IPO priced $20 per share, which is $3 above the upper limit of the previously announced range ($14-17). Besides, AbCellera has granted the underwriters a 30-day option to purchase up to 3 622 500 shares of common stock at the public offering price. 

The trading debut will take place on the Nasdaq Global Select Market on December 11, 2020 under the ticker symbol “ABCL”.